Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NCI-H290 |
Human pleural malignant mesothelioma cell line | Human | unknown | cell line | plasmid | stable transfection | Metafectene | publication | S. Abe et al., Cancer Sci., 2016, 107: 1198-1205; doi: 10.1111/cas.12985 | Link | |||
NCI-H295 |
Human adrenal carcinoma cell line | Human | other | cell line | adherent | plasmid | Metafectene | publication | I. K. Johnsen et al., Cancer Res., Jul 2009; 69: 5784 - 5792 | Link | |||
NCI-H295R |
Human adrenal gland carcinoma cell line | ATCC CRL-2128 | Human | other | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Sugawara et al., J. Biol. Chem., Oct 2003; 278: 42487 - 42494 | Link | |
NCI-H295R |
Human adrenocortical carcinoma cell line | ATCC CRL-2128 | Human | other | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Sugawara et al., J. Endocrinol., Oct 2006; 191: 327 - 337 | Link | |
NCI-H441-eGFP |
Human lung papillary adenocarcinoma cell line, stably expressing eGFP (derivat of NCI-H441) | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. del Pino et al., Nano Lett, Oct 2010; 10(10): 3914-21 | |||
NCI-H460 |
Human large cell lung carcinoma cell line | ATCC HTB-177 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Kim et al., Cancer Letters, 2013, 339: 15–24, doi.org/10.1016/j.canlet.2013.07.027 | Link | |
NCI-H460 |
Human large cell lung carcinoma cell line | ATCC HTB-177 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | M.-J. Kim et al., Cancer Letters, 2013, 339: 15–24, doi.org/10.1016/j.canlet.2013.07.027 | Link | ||
NLF |
Human neuroblastoma cells | Human | unknown | unknown | plasmid | RNA-Interference | Metafectene | publication | S. Vomund et al., Cereb Cortex, Mar 2016; 10.1093/cercor/bhw060 | Link | |||
NLF |
Human neuroblastoma cells | Human | unknown | unknown | plasmid | Metafectene | publication | V. Bader et al., Hum. Mol. Genet., Oct 2012; 21: 4406 - 4418 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | P. J. Hendriks, Dissertation, 2012, Heinrich-Heine-Universität Düsseldorf | Link | |||
NLF |
Human neuroblastoma cells | Human | unknown | unknown | plasmid | Metafectene | publication | S. Vomund et al., Cereb Cortex, Mar 2016; 10.1093/cercor/bhw060 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | A. S. K.Yerabham et al., PLOSONE, 2018, doi.org/10.1371/journal.pone.0191162 | Link | ||||
NLF |
Human neuroblastoma cells | Human | unknown | unknown | plasmid | Metafectene | publication | S. R. Leliveld et al., J. Neurosci., Apr 2008; 28: 3839 - 3845 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | RNA-Interference | Metafectene | publication | S. Vomund et al., Cerebral Cortex,March 2017, 27: 2052-2063 | Link | |||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | V. Bader et al., J. of Visualized Experiments, DOI: doi:10.3791/4132 | Link | ||||
NLF |
Human neuroblastoma cell line | Human | unknown | cell line | plasmid | Metafectene | publication | N. .J. Bradshaw et al., PLoS ONE, 2014, 9 (10): e111196, doi:10.1371/journal.pone.0111196 | Link | ||||
NT2D1 |
Human malignant pluripotent embryonal carcinoma stem cell line | ATCC CRL-1973 | Human | genital tract | stem cell | adherent | plasmid | Metafectene | publication | L. Sessa et al., RNA, Feb 2007; 13: 223 - 239 | Link | ||
OST TK1- |
Human osteosarcoma cell line, defficient of TK1 | Human | bone | cell line | plasmid | Metafectene | publication | C. Rampazzo et al., J. Biol. Chem., Apr 2004; 279: 17019 - 17026 | Link | ||||
P skin fibroblasts |
Human immortalized skin fibroblasts (patient derived) | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Benincá et al., J. Med. Genet., 2021, 58: 155–167, doi:10.1136/jmedgenet-2020-106861 | Link | ||
Panc |
Human exocrine pancreas carcinoma cells | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | |||
Panc |
Human pancreas carcinoma cells | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | |||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | N. Walter et al., Am. Vac. Biointerphases, 2011, 6(2), DOI: 10.1116/1.3601755 | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | application note | ![]() |